CA2113555A1 - Cellules-souches de la vesicule ombilicale - Google Patents

Cellules-souches de la vesicule ombilicale

Info

Publication number: CA2113555A1
Authority: CA; Canada
Prior art keywords: cells; yolk sac; stem cells; animal; mhc class
Prior art date: 1991-07-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002113555A

Other languages

English (en)

Inventor

Thomas E. Wagner

Michael R. Antczak

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ohio University

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-15

Filing date

1992-07-14

Publication date

1993-02-04

1992-07-14 Application filed by Individual filed Critical Individual

1993-02-04 Publication of CA2113555A1 publication Critical patent/CA2113555A1/fr

Status Abandoned legal-status Critical Current

Links

210000001325 yolk sac Anatomy 0.000 title claims abstract description 221
210000000130 stem cell Anatomy 0.000 title claims abstract description 56
210000000601 blood cell Anatomy 0.000 claims abstract description 35
210000004369 blood Anatomy 0.000 claims abstract description 27
239000008280 blood Substances 0.000 claims abstract description 27
230000003394 haemopoietic effect Effects 0.000 claims abstract description 16
230000015572 biosynthetic process Effects 0.000 claims abstract description 15
210000000777 hematopoietic system Anatomy 0.000 claims abstract description 12
238000012258 culturing Methods 0.000 claims abstract description 7
238000000034 method Methods 0.000 claims description 43
241001465754 Metazoa Species 0.000 claims description 38
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 19
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 19
238000001727 in vivo Methods 0.000 claims description 19
238000000338 in vitro Methods 0.000 claims description 16
230000000735 allogeneic effect Effects 0.000 claims description 13
210000001161 mammalian embryo Anatomy 0.000 claims description 13
230000035935 pregnancy Effects 0.000 claims description 12
210000004291 uterus Anatomy 0.000 claims description 12
241001494479 Pecora Species 0.000 claims description 10
241000283707 Capra Species 0.000 claims description 9
108010002386 Interleukin-3 Proteins 0.000 claims description 8
102000000646 Interleukin-3 Human genes 0.000 claims description 8
239000003795 chemical substances by application Substances 0.000 claims description 7
239000003102 growth factor Substances 0.000 claims description 4
108010002350 Interleukin-2 Proteins 0.000 claims description 3
102000000588 Interleukin-2 Human genes 0.000 claims description 3
230000002401 inhibitory effect Effects 0.000 claims description 3
108010092408 Eosinophil Peroxidase Proteins 0.000 claims description 2
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 2
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 2
102000043131 MHC class II family Human genes 0.000 claims description 2
108091054438 MHC class II family Proteins 0.000 claims description 2
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 2
102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 claims description 2
230000024245 cell differentiation Effects 0.000 claims description 2
239000000203 mixture Substances 0.000 claims 8
230000001413 cellular effect Effects 0.000 claims 5
102100028471 Eosinophil peroxidase Human genes 0.000 claims 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 1
241000725303 Human immunodeficiency virus Species 0.000 claims 1
208000032839 leukemia Diseases 0.000 claims 1
210000004027 cell Anatomy 0.000 abstract description 297
239000000427 antigen Substances 0.000 abstract description 26
108091007433 antigens Proteins 0.000 abstract description 26
102000036639 antigens Human genes 0.000 abstract description 26
230000007774 longterm Effects 0.000 abstract description 25
238000002560 therapeutic procedure Methods 0.000 abstract description 11
238000004519 manufacturing process Methods 0.000 abstract description 8
210000000265 leukocyte Anatomy 0.000 abstract description 7
238000012360 testing method Methods 0.000 abstract description 6
230000002950 deficient Effects 0.000 abstract description 5
229940079593 drug Drugs 0.000 abstract description 4
239000003814 drug Substances 0.000 abstract description 4
230000036737 immune function Effects 0.000 abstract description 4
108700018351 Major Histocompatibility Complex Proteins 0.000 abstract description 3
230000004075 alteration Effects 0.000 abstract description 3
238000010276 construction Methods 0.000 abstract description 3
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 abstract description 3
238000010171 animal model Methods 0.000 abstract description 2
238000012512 characterization method Methods 0.000 abstract description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
238000009169 immunotherapy Methods 0.000 abstract description 2
201000010099 disease Diseases 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1
241000699670 Mus sp. Species 0.000 description 38
241000699666 Mus <mouse, genus> Species 0.000 description 26
210000001185 bone marrow Anatomy 0.000 description 21
210000002969 egg yolk Anatomy 0.000 description 21
241001529936 Murinae Species 0.000 description 20
210000002257 embryonic structure Anatomy 0.000 description 20
108090000623 proteins and genes Proteins 0.000 description 19
210000000952 spleen Anatomy 0.000 description 18
230000004069 differentiation Effects 0.000 description 17
210000001519 tissue Anatomy 0.000 description 17
238000002054 transplantation Methods 0.000 description 17
102000004058 Leukemia inhibitory factor Human genes 0.000 description 15
108090000581 Leukemia inhibitory factor Proteins 0.000 description 15
210000001744 T-lymphocyte Anatomy 0.000 description 14
210000002540 macrophage Anatomy 0.000 description 14
238000002347 injection Methods 0.000 description 11
239000007924 injection Substances 0.000 description 11
230000012010 growth Effects 0.000 description 10
238000011579 SCID mouse model Methods 0.000 description 9
238000011161 development Methods 0.000 description 9
230000018109 developmental process Effects 0.000 description 9
239000002158 endotoxin Substances 0.000 description 9
210000003743 erythrocyte Anatomy 0.000 description 9
229920006008 lipopolysaccharide Polymers 0.000 description 9
210000004185 liver Anatomy 0.000 description 9
238000011282 treatment Methods 0.000 description 9
COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 8
102100020880 Kit ligand Human genes 0.000 description 8
229960002092 busulfan Drugs 0.000 description 8
210000003958 hematopoietic stem cell Anatomy 0.000 description 8
230000011132 hemopoiesis Effects 0.000 description 8
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 8
241000894007 species Species 0.000 description 8
238000012546 transfer Methods 0.000 description 8
102100031939 Erythropoietin Human genes 0.000 description 7
108091006905 Human Serum Albumin Proteins 0.000 description 7
102000008100 Human Serum Albumin Human genes 0.000 description 7
210000003754 fetus Anatomy 0.000 description 7
238000000684 flow cytometry Methods 0.000 description 7
210000000056 organ Anatomy 0.000 description 7
102000004127 Cytokines Human genes 0.000 description 6
108090000695 Cytokines Proteins 0.000 description 6
102000043129 MHC class I family Human genes 0.000 description 6
108091054437 MHC class I family Proteins 0.000 description 6
101150052863 THY1 gene Proteins 0.000 description 6
210000003719 b-lymphocyte Anatomy 0.000 description 6
238000002955 isolation Methods 0.000 description 6
239000002609 medium Substances 0.000 description 6
206010068051 Chimerism Diseases 0.000 description 5
241000282412 Homo Species 0.000 description 5
210000002798 bone marrow cell Anatomy 0.000 description 5
238000010322 bone marrow transplantation Methods 0.000 description 5
230000000694 effects Effects 0.000 description 5
230000001605 fetal effect Effects 0.000 description 5
210000003714 granulocyte Anatomy 0.000 description 5
210000004379 membrane Anatomy 0.000 description 5
239000012528 membrane Substances 0.000 description 5
230000004044 response Effects 0.000 description 5
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 4
238000011740 C57BL/6 mouse Methods 0.000 description 4
238000013459 approach Methods 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
210000004748 cultured cell Anatomy 0.000 description 4
230000013020 embryo development Effects 0.000 description 4
230000006870 function Effects 0.000 description 4
102000054766 genetic haplotypes Human genes 0.000 description 4
210000004698 lymphocyte Anatomy 0.000 description 4
210000003593 megakaryocyte Anatomy 0.000 description 4
OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 4
230000010076 replication Effects 0.000 description 4
230000001177 retroviral effect Effects 0.000 description 4
230000004083 survival effect Effects 0.000 description 4
229950002929 trinitrophenol Drugs 0.000 description 4
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
108010045198 H-2 Antigens Proteins 0.000 description 3
206010061598 Immunodeficiency Diseases 0.000 description 3
229910000831 Steel Inorganic materials 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
239000002246 antineoplastic agent Substances 0.000 description 3
230000011712 cell development Effects 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
239000012634 fragment Substances 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
208000024908 graft versus host disease Diseases 0.000 description 3
230000016784 immunoglobulin production Effects 0.000 description 3
230000006698 induction Effects 0.000 description 3
230000000998 lymphohematopoietic effect Effects 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
239000003550 marker Substances 0.000 description 3
210000005259 peripheral blood Anatomy 0.000 description 3
239000011886 peripheral blood Substances 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
239000010959 steel Substances 0.000 description 3
241000606125 Bacteroides Species 0.000 description 2
238000011735 C3H mouse Methods 0.000 description 2
101150096672 CEL1 gene Proteins 0.000 description 2
208000031886 HIV Infections Diseases 0.000 description 2
208000037357 HIV infectious disease Diseases 0.000 description 2
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 2
102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
206010052779 Transplant rejections Diseases 0.000 description 2
208000036142 Viral infection Diseases 0.000 description 2
238000002679 ablation Methods 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
230000005875 antibody response Effects 0.000 description 2
210000000612 antigen-presenting cell Anatomy 0.000 description 2
238000003556 assay Methods 0.000 description 2
230000008901 benefit Effects 0.000 description 2
239000002771 cell marker Substances 0.000 description 2
238000002512 chemotherapy Methods 0.000 description 2
229940044683 chemotherapy drug Drugs 0.000 description 2
238000010367 cloning Methods 0.000 description 2
230000001332 colony forming effect Effects 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
210000003785 decidua Anatomy 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
238000012137 double-staining Methods 0.000 description 2
230000000925 erythroid effect Effects 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
230000008105 immune reaction Effects 0.000 description 2
230000028993 immune response Effects 0.000 description 2
230000001506 immunosuppresive effect Effects 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
210000001616 monocyte Anatomy 0.000 description 2
230000001338 necrotic effect Effects 0.000 description 2
230000005868 ontogenesis Effects 0.000 description 2
230000037361 pathway Effects 0.000 description 2
239000008188 pellet Substances 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
239000000047 product Substances 0.000 description 2
238000001959 radiotherapy Methods 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
239000007787 solid Substances 0.000 description 2
210000002023 somite Anatomy 0.000 description 2
230000003393 splenic effect Effects 0.000 description 2
238000010186 staining Methods 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
239000000126 substance Substances 0.000 description 2
230000009466 transformation Effects 0.000 description 2
210000004881 tumor cell Anatomy 0.000 description 2
210000002700 urine Anatomy 0.000 description 2
210000003462 vein Anatomy 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 1
102000055025 Adenosine deaminases Human genes 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
-1 CSF's Proteins 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
102000053642 Catalytic RNA Human genes 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
101100130497 Drosophila melanogaster Mical gene Proteins 0.000 description 1
101100426999 Drosophila melanogaster tutl gene Proteins 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
102000003951 Erythropoietin Human genes 0.000 description 1
108090000394 Erythropoietin Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
208000009329 Graft vs Host Disease Diseases 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
208000002250 Hematologic Neoplasms Diseases 0.000 description 1
108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
101150017040 I gene Proteins 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
108700005092 MHC Class II Genes Proteins 0.000 description 1
206010064912 Malignant transformation Diseases 0.000 description 1
102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
101710087603 Mast/stem cell growth factor receptor Kit Proteins 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
101100345589 Mus musculus Mical1 gene Proteins 0.000 description 1
BKAYIFDRRZZKNF-VIFPVBQESA-N N-acetylcarnosine Chemical compound CC(=O)NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BKAYIFDRRZZKNF-VIFPVBQESA-N 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
208000001388 Opportunistic Infections Diseases 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
206010057249 Phagocytosis Diseases 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
241000700159 Rattus Species 0.000 description 1
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
108010039445 Stem Cell Factor Proteins 0.000 description 1
206010043395 Thalassaemia sickle cell Diseases 0.000 description 1
241000906446 Theraps Species 0.000 description 1
241000193803 Therea Species 0.000 description 1
241000700605 Viruses Species 0.000 description 1
241000021375 Xenogenes Species 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
206010000210 abortion Diseases 0.000 description 1
231100000176 abortion Toxicity 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
210000001691 amnion Anatomy 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
230000030741 antigen processing and presentation Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
229940041181 antineoplastic drug Drugs 0.000 description 1
238000000149 argon plasma sintering Methods 0.000 description 1
210000001367 artery Anatomy 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 1
210000000625 blastula Anatomy 0.000 description 1
210000001772 blood platelet Anatomy 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
244000309466 calf Species 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
230000011748 cell maturation Effects 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000005757 colony formation Effects 0.000 description 1
230000002281 colonystimulating effect Effects 0.000 description 1
238000004891 communication Methods 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000003636 conditioned culture medium Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
238000012136 culture method Methods 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000002224 dissection Methods 0.000 description 1
210000002308 embryonic cell Anatomy 0.000 description 1
210000001900 endoderm Anatomy 0.000 description 1
210000003038 endothelium Anatomy 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000006862 enzymatic digestion Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
229940105423 erythropoietin Drugs 0.000 description 1
230000004720 fertilization Effects 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000009395 genetic defect Effects 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000035931 haemagglutination Effects 0.000 description 1
230000009033 hematopoietic malignancy Effects 0.000 description 1
108060003552 hemocyanin Proteins 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
210000002865 immune cell Anatomy 0.000 description 1
230000003832 immune regulation Effects 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
238000001802 infusion Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
231100000636 lethal dose Toxicity 0.000 description 1
239000003446 ligand Substances 0.000 description 1
108010052322 limitin Proteins 0.000 description 1
230000036212 malign transformation Effects 0.000 description 1
230000010311 mammalian development Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
230000035800 maturation Effects 0.000 description 1
210000003519 mature b lymphocyte Anatomy 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
239000011707 mineral Substances 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
210000000472 morula Anatomy 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
230000035772 mutation Effects 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
230000010309 neoplastic transformation Effects 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000002245 particle Substances 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
230000002688 persistence Effects 0.000 description 1
230000008782 phagocytosis Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
210000004180 plasmocyte Anatomy 0.000 description 1
210000001778 pluripotent stem cell Anatomy 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
229920000447 polyanionic polymer Polymers 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
230000002980 postoperative effect Effects 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000009877 rendering Methods 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
230000002629 repopulating effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000012090 serum-supplement Substances 0.000 description 1
208000007056 sickle cell anemia Diseases 0.000 description 1
239000008279 sol Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
210000001082 somatic cell Anatomy 0.000 description 1
229960002385 streptomycin sulfate Drugs 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
230000001629 suppression Effects 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
238000004448 titration Methods 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
230000005740 tumor formation Effects 0.000 description 1
231100000588 tumorigenic Toxicity 0.000 description 1
230000000381 tumorigenic effect Effects 0.000 description 1
230000035899 viability Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/14—Erythropoietin [EPO]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Biotechnology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Cell Biology (AREA)
General Health & Medical Sciences (AREA)
Reproductive Health (AREA)
Developmental Biology & Embryology (AREA)
Gynecology & Obstetrics (AREA)
Hematology (AREA)
Immunology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pregnancy & Childbirth (AREA)
Virology (AREA)
Epidemiology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

CA002113555A 1991-07-15 1992-07-14 Cellules-souches de la vesicule ombilicale Abandoned CA2113555A1 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US73025091A	1991-07-15	1991-07-15
US730,250		1991-07-15
US88037592A	1992-05-08	1992-05-08
US880,375		1992-05-08

Publications (1)

Publication Number	Publication Date
CA2113555A1 true CA2113555A1 (fr)	1993-02-04

Family

ID=27112018

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002113555A Abandoned CA2113555A1 (fr)	1991-07-15	1992-07-14	Cellules-souches de la vesicule ombilicale

Country Status (5)

Country	Link
EP (1)	EP0594725A4 (fr)
JP (1)	JPH06508762A (fr)
AU (1)	AU661709B2 (fr)
CA (1)	CA2113555A1 (fr)
WO (1)	WO1993002182A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5744347A (en) *	1987-01-16	1998-04-28	Ohio University Edison Biotechnology Institute	Yolk sac stem cells and their uses
US5437766A (en) *	1993-10-22	1995-08-01	The Procter & Gamble Company	Multi-ply facial tissue paper product comprising biodegradable chemical softening compositions and binder materials
US5599705A (en) *	1993-11-16	1997-02-04	Cameron; Robert B.	In vitro method for producing differentiated universally compatible mature human blood cells
CN120290455A (zh) *	2018-11-08	2025-07-11	整合培育株式会社	动物细胞增殖促进剂、动物细胞培养用培养基和动物细胞培养装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4497796A (en) *	1980-03-26	1985-02-05	The Regents Of The University Of California	Gene transfer in intact mammals
US5032407A (en) *	1987-01-16	1991-07-16	Ohio University Edison Animal Biotechnology Center	Gene transfer using transformed, neodetermined, embryonic cells

1992
- 1992-07-14 EP EP19920915474 patent/EP0594725A4/fr not_active Withdrawn
- 1992-07-14 WO PCT/US1992/005918 patent/WO1993002182A1/fr not_active Ceased
- 1992-07-14 CA CA002113555A patent/CA2113555A1/fr not_active Abandoned
- 1992-07-14 JP JP5502931A patent/JPH06508762A/ja active Pending
- 1992-07-14 AU AU23248/92A patent/AU661709B2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2324892A (en)	1993-02-23
JPH06508762A (ja)	1994-10-06
EP0594725A4 (fr)	1994-11-30
AU661709B2 (en)	1995-08-03
EP0594725A1 (fr)	1994-05-04
WO1993002182A1 (fr)	1993-02-04

Legal Events

Date	Code	Title	Description
2000-07-14	FZDE	Discontinued
2023-05-26	FZDE	Discontinued	Effective date: 20000714

Publication	Publication Date	Title
AU701752B2 (en)	1999-02-04	Yolk sac stem cells and their uses
US6093531A (en)	2000-07-25	Generation of hematopoietic cells from multipotent neural stem cells
US5599703A (en)	1997-02-04	In vitro amplification/expansion of CD34+ stem and progenitor cells
US20030124091A1 (en)	2003-07-03	Endothelial cell derived hematopoietic growth factor
JPH11514879A (ja)	1999-12-21	原始ヒト幹細胞を有するＭｐ１リガンドの使用法
WO2012133948A1 (fr)	2012-10-04	Composition pour thérapie cellulaire par allogreffe, ladite composition contenant une cellule souche pluripotente positive pour ssea-3 pouvant être isolée de tissu corporel
US6821513B1 (en)	2004-11-23	Method for enhancing hematopoiesis
AU2008277391A1 (en)	2009-01-22	Culture for expanding stem cells ex-vivo
CA2113555A1 (fr)	1993-02-04	Cellules-souches de la vesicule ombilicale
US20040076620A1 (en)	2004-04-22	Method of repairing primate mammalian tissue
WO1999003980A1 (fr)	1999-01-28	Cellules de stroma derivees d'agm
US20110052545A1 (en)	2011-03-03	Regeneration system, its production and use
WO1998012304A1 (fr)	1998-03-26	Systeme de mise en culture de cellules souches hematopoietiques
WO2025174985A1 (fr)	2025-08-21	Progéniteurs plaquettaires pour thrombocytopénie
Péault et al.	1999	Haematopoietic stem cell emergence and development in the human embryo and fetus; perspectives for blood cell therapies in utero
AU5764700A (en)	2001-01-09	Method for enhancing hematopoiesis
WO2005033299A1 (fr)	2005-04-14	Procede de reparation d'un tissu de mammifere primate
JPWO1999003980A1 (ja)	2002-08-06	Ａｇｍ領域由来ストローマ細胞
MXPA06002377A (en)	2006-12-13	Method of repairing primate mammalian tissue